Dengfeng Gao

Prof. Dr. Dengfeng Gao

Xi'an Jiaotong University, Shaanxi, Xi'an, China
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
GZGuoxu Zhao
Guoxu Zhao
YFYanjing Feng
Yanjing Feng
LXLi Xue
Li Xue
MCMengjie Cui
Mengjie Cui
QZQi Zhang
Qi Zhang
XZXiaohui Zhang
Xiaohui Zhang

26 February 2021 in Aging
Verified
Journal Article
Open access
DGDengfeng Gao
Dengfeng Gao
MXMin Xu
Min Xu
GWGang Wang
Gang Wang
JLJianrui Lv
Jianrui Lv
XMXiaorong Ma
Xiaorong Ma
SGShouping Gong
Shouping Gong
The inflammatory reaction is the main cause of acute respiratory distress syndrome and multiple organ failure in patients with Coronavirus disease 2019, especially those with severe and critical illness. Several studies suggested that high-dose vitamin C reduced inflammatory reaction associated with sepsis and acute respiratory distress syndrome. This study aimed to determine the efficacy and safety of high-dose vitamin C in Coronavirus disease 2019. We included 76 patients with Coronavirus disease 2019, classified into the high-dose vitamin C group (loading dose of 6g intravenous infusion per 12 hr on the first day, and 6g once for the following 4 days, n=46) and the standard therapy group (standard therapy alone, n=30). The risk of 28-day mortality was reduced for the high-dose vitamin C versus the standard therapy group (HR=0.14, 95% CI, 0.03-0.72). Oxygen support status was improved more with high-dose vitamin C than standard therapy (63.9% vs 36.1%). No safety events were associated with high-dose vitamin C therapy. High-dose vitamin C may reduce the mortality and improve oxygen support status in patients with Coronavirus disease 2019 without adverse events.

19 May 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
MYMiao Yuan
Miao Yuan
FRFuxian Ren
Fuxian Ren
DGDengfeng Gao
Dengfeng Gao
Background. The main purpose of this study was to explore the predictive value of the systemic immune inflammation index (SII), a novel clinical marker, in heart failure (HF) patients. Methods. Critically ill patients with HF were identified from the Medical Information Mart for Intensive Care III (MIMIC III) database. Patients were divided into three groups according to tertiles of SII (group 1, group 2, group 3). We used Kaplan-Meier curves and Cox proportional hazards regression models to evaluate the association between the SII and all-cause mortality in HF. Subgroup analysis was used to verify the predictive effect of the SII on mortality. Results. This study included 9107 patients with a diagnosis of HF from the MIMIC III database. After 30, 60, 180, and 365 days of follow-up, 25.60%, 32.10%, 41.30%, and 47.50% of the patients in group 3 had died. Using the Kaplan-Meier curve, we observed that patients with higher SII values had a shorter survival time (log rank ). The Cox proportional hazards regression model adjusted for all possible confounders and indicated that the higher SII group had a higher mortality (30-day: , , 60-day: , 95% , 180-day: , , and 365-day: , ). Conclusions. SII values could be used as a predictor of prognosis in critically ill patients with HF.

7 April 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
YWYu Wang
Yu Wang
MYMiao Yuan
Miao Yuan
YMYao Ma
Yao Ma
CSCongcong Shao
Congcong Shao
YWYuan Wang
Yuan Wang
DGDengfeng Gao
Dengfeng Gao
Purpose: Peripheral differential leukocyte counts are accepted prognostic indicators in patients with acute myocardial infarction (AMI). Herein, we assessed the value of the admission (neutrophil+monocyte)/lymphocyte ratio (NMLR) in predicting in-hospital mortality in these patients.Materials and Methods: Samples of patients from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database meeting the criteria were included. Receiver operating characteristic (ROC) curves were plotted to explore the predictive value and the optimum cut-off value of admission NMLR. Univariate and multivariate Cox regression analyses and restricted cubic spline (RCS) were performed to determine and visualize the association between admission NMLR and in-hospital mortality. The Kaplan-Meier (KM) method was used to plot survival curves of two groups with different admission NMLR levels.Results: Samples in the non-survival group had higher admission NMLR values than samples in the survival group (12.11 [7.22–21.05] vs. 6.38 [3.96–11.25], P < 0.05). The area under the ROC curve (AUROC) [0.707 (95% Confidence Interval, 0.677–0.737)] was significantly better than those of other indicators related to peripheral differential leukocyte counts, and the optimal cut-off value was 8.518. Cox regression analysis identified that higher admission NMLR was an independent risk factor for in-hospital mortality. RCS visualized the uptrend and the non-linear relationship between admission NMLR and in-hospital mortality (P-value for non-linearity <0.05). The KM survival curve of the high admission NMLR group was significantly lower than that of the low admission NMLR group (P < 0.001), and the former was associated with an increased risk of in-hospital mortality compared to the latter (Hazard Ratio, 1.452; 95% Confidence Interval, 1.132–1.862; P < 0.05).Conclusion: An elevated admission NMLR is an independent predictor for high in-hospital mortality in patients with AMI. And it is superior to other leukocyte-related indexes.

15 November 2022 in Journal of Human Nutrition and Dietetics
Verified
Journal Article
Closed access
XXXin Xing
Xin Xing
MXMin Xu
Min Xu
LYLijun Yang
Lijun Yang
CSCongcong Shao
Congcong Shao
YWYuan Wang
Yuan Wang
DGDengfeng Gao
Dengfeng Gao

15 September 2020 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
WZWenqian Zhang
Wenqian Zhang
QWQiaozhu Wang
Qiaozhu Wang
YFYanjing Feng
Yanjing Feng
XCXuegui Chen
Xuegui Chen
LYLijun Yang
Lijun Yang
DGDengfeng Gao
Dengfeng Gao
Background: Hypertensive myocardial fibrosis (MF) is characterized by excessive deposition of extracellular matrix and cardiac fibroblast proliferation, which can lead to heart failure, malignant arrhythmia, and sudden death. In recent years, with the deepening of research, microRNAs have been found to have an important role in blood pressure control and maintaining normal ventricular structure and function. Methods and Results: In this study, we first documented the downregulation of microRNA‐26a (miR‐26a) in the plasma and myocardium of spontaneously hypertensive rats; more importantly, miR‐26a–deficient mice showed MF, whereas overexpression of miR‐26a significantly prevented elevated blood pressure and inhibited MF in vivo and angiotensin II‐induced fibrogenesis in cardiac fibroblasts by directly targeting connective tissue growth factor and Smad4. miR‐26a inhibited cardiac fibroblast proliferation by the enhancer of zeste homolog 2/p21 pathway. Conclusions: Our study identified a novel role for miR‐26a in blood pressure control and hypertensive MF and provides a possible treatment strategy for miR‐26a to alleviate and reverse hypertensive MF.